Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban

The effect of direct oral anticoagulants (DOACs) on laboratory tests dependent on the production of their targets, factor IIa and factor Xa (FXa), is a well-known problem and can cause both false positive and negative results. Therefore, the correct interpretation of tests performed in patients rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Slavik, L., Jacova, J., Friedecky, D., Ulehlova, J., Tauber, Z., Prochazkova, J., Hlusi, A., Palova, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Biomarkers for Evaluating the Risk and Prognosis of Vascular Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829642/
https://www.ncbi.nlm.nih.gov/pubmed/31523979
http://dx.doi.org/10.1177/1076029619872556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829642/
https://www.ncbi.nlm.nih.gov/pubmed/31523979
http://dx.doi.org/10.1177/1076029619872556

Ejemplares similares